Association between maternal and amniotic fluid cortisol is moderated by maternal anxiety

https://doi.org/10.1016/j.psyneuen.2008.10.005Get rights and content

Summary

Maternal stress or anxiety during pregnancy can lead to neurodevelopmental and other problems in the child, and cortisol is one possible mediator. Animal models show that maternal prenatal stress can affect placental function, including regulation of placental 11β-HSD2, the main barrier to the placental passage of cortisol. It is not known whether a parallel process exists in humans. The aim of the current study was to determine whether maternal anxiety increases the association between maternal plasma cortisol and amniotic fluid cortisol. The sample consisted of 262 women having amniocentesis, with normal pregnancies, who completed Spielberger State and Trait anxiety scales, from whom a plasma sample and an aliquot of amniotic fluid was obtained. The correlation between maternal and amniotic fluid cortisol was strongly dependent on both State and Trait maternal anxiety; in the most anxious State quartile r(62) = .59, p < .001 and in the least r(60) = .05, ns, a significant difference (p < .0015). The moderating effect of maternal anxiety on the association between maternal plasma and amniotic fluid cortisol remained when gestational age, maternal age, fetal sex, medication and time of collection were controlled for. There was no difference in amniotic fluid cortisol levels between the most and least anxious groups of mothers. However, the finding that there is a stronger correlation between maternal and fetal cortisol among more anxious pregnant women does suggests that the maternal emotional state can affect the function of the placenta.

Introduction

There is good evidence from animal studies, and increasing evidence in humans, that prenatal stress can have long term-effects on the child, including on neurodevelopment (Van den Bergh et al., 2005, Talge et al., 2007). The increased risk for child cognitive and behavioral problems is found with moderate elevations of anxiety and in non-selected samples e.g., (O’Connor et al., 2002, O’Connor et al., 2003), and is independent of postnatal anxiety and depression (O’Connor et al., 2002, Bergman et al., 2007). In rodent models it has been shown that the effects of prenatal stress on the offspring are at least partly mediated via the hypothalamic–pituitary–adrenal (HPA) axis, particularly exposure to glucocorticoids (Weinstock, 2001, Herbert et al., 2006, Seckl and Holmes, 2007). Non-human primate models also point to the mediating role of the HPA axis (Schneider et al., 2002). The potentially widespread role for exposure to increased cortisol in human fetal brain development has been strengthened by a study showing, by microarray analysis, that increased cortisol exposure affects the expression of over a thousand genes in fetal brain cells (Salaria et al., 2006).

It is, however, less clear that cortisol, or the function of the maternal HPA axis, mediates the long-term effects of antenatal maternal stress on the fetus in humans. Only modest associations between maternal antenatal anxiety and maternal cortisol levels have been reported (Sarkar et al., 2006, Obel et al., 2005) and there is some evidence that maternal prenatal stress/anxiety predicts infant outcomes independent of maternal prenatal cortisol levels (Davis et al., 2007; Bergman, Sarkar, O’Connor and Glover unpublished observations). Also, the maternal HPA axis becomes hypo-responsive to stress as gestation increases (Schulte et al., 1990, Kammerer et al., 2002) and at least in some studies, this is the stage at which antenatal stress has the greatest effect on fetal development (O’Connor et al., 2002).

Perturbations in the maternal environment must be transmitted across the placenta in order to affect the fetus, and it is possible that alterations in the function of the placenta may play an important part in regulating the exposure of the fetus to maternal hormone levels, independently of a direct increase in maternal cortisol (Jansson and Powell, 2007). Two recent rodent studies have shown that maternal prenatal stress can affect the function of the placenta, including the expression and activity of 11beta-hydroxysteroid dehydrogenase 2 (11β-HSD2) (Welberg et al., 2005, Mairesse et al., 2007). This is the enzyme that metabolises cortisol to the inactive cortisone in the placenta, and thus regulates maternal to fetal transfer of glucocorticoids. If the enzyme is downregulated by prenatal stress, as shown in rodents by Mairesse et al. (2007), one would expect more cortisol to pass from mother to fetus, and possibly contribute to fetal programming effects. In humans lower placental levels of 11β-HSD2. (Kajantie et al., 2003, Dy et al., 2008), and mutations in the gene encoding it (Seckl and Holmes, 2007) have been found to be associated with intrauterine growth restriction, possibly due to increased fetal exposure to cortisol.

In the current study we aimed to translate the rodent study of Mairesse et al. (2007) as part of a series of studies on prenatal anxiety/stress and child development (Sarkar et al., 2006, Sarkar et al., 2007a, Sarkar et al., 2007b, Bergman et al., 2007). We have previously reported a significant association between maternal plasma and amniotic fluid cortisol, which increases with gestational age (Sarkar et al., 2007a). Here we have tested the hypothesis that the association between amniotic fluid and maternal plasma cortisol is increased with maternal anxiety and is greater among more anxious mothers. We also determined whether amniotic fluid cortisol was raised in the more anxious mothers.

Section snippets

Subjects and methods

This study was conducted at Queen Charlotte's and Chelsea Hospital, London and involved obtaining maternal plasma and amniotic fluid samples from pregnant women undergoing amniocentesis for karyotyping to identify chromosome anomalies, the majority for Down's syndrome. A total of 365 subjects with a gestational age range of 15–37 weeks were recruited between December 2001 and December 2004. All women gave written informed consent as approved by the institutional ethics committee. All subjects

Results

The characteristics of the sample are shown in Table 1. It may be seen that the cortisol levels in maternal plasma were about 28 fold higher than those in the amniotic fluid. There was a positive correlation between amniotic fluid cortisol with maternal plasma levels (r = .32, p < .001), in the group as a whole.

Fig. 1 shows the correlations between maternal plasma and amniotic fluid cortisol in the mothers according to maternal State anxiety quartiles. In the most anxious group the correlation was r

Discussion

This study is the first to examine the possible effects of maternal mood on placental function in humans. It supports the hypothesis that if the mother is anxious while pregnant then there is a greater association between her cortisol level and that of her fetus, and suggests that the emotional state of the mother may have a direct effect on placental function. There was a similar stepped relationship between maternal/amniotic fluid cortisol correlation and both State and Trait anxiety (Figure 1

Role of the funding sources

Funding for this study was provided by March of Dimes; March of Dimes had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.

Conflict of interest

None of the authors have any actual or potential conflict of interest related to the submitted manuscript.

Acknowledgement

We should like to thank March of Dimes for funding and Diana Adams for help with the recruitment of the subjects, scoring of the questionnaires and data collection, and Kieran O’Donnell for helpful discussion of the findings.

References (27)

  • J. Herbert et al.

    Do corticosteroids damage the brain?

    J. Neuroendocrinol.

    (2006)
  • M.C. Holmes et al.

    The mother or the fetus? 11beta-hydroxysteroid dehydrogenase type 2 null mice provide evidence for direct fetal programming of behavior by endogenous glucocorticoids

    J. Neurosci.

    (2006)
  • T. Jansson et al.

    Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches

    Clin. Sci. (Lond.)

    (2007)
  • Cited by (0)

    View full text